Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
J Hosp Infect ; 104(2): 150-157, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31605739

ABSTRACT

BACKGROUND: Preprescription authorization (PPA) and postprescription review with feedback (PPRF) were successively implemented in 2012 and 2016 in our 1500-bed hospital. AIM: The impact of PPA and PPRF on carbapenems use and resistance levels of Pseudomonas aeruginosa was assessed in three intensive care units (ICUs). METHODS: Carbapenems use (in DDDs/1000 occupied bed-days) and resistance of P. aeruginosa (percentage of non-susceptible (I+R) isolates to imipenem and/or meropenem) were analysed using a controlled interrupted time-series method. Two periods were compared: 2012-2015 (PPA) and 2016-2017 (PPA+PPRF). Models were adjusted on the annual incidence of extended-spectrum ß-lactamase-producing enterobacteriacae. FINDINGS: Carbapenem use was stable over the PPA period in all ICUs, with a significant change of slope over the PPA+PPRF period only in ICU1 (ß2 = -12.8, 95% confidence interval (CI) = -19.5 to -6.1). There was a switch from imipenem to meropenem during the PPA period in all three units. Resistances of P. aeruginosa were stable over the study period in ICU1 and ICU2, and significantly decreased over the PPA+PPRF period in ICU3 (ß2 = -0.18, CI = -0.3 to -0.03). CONCLUSION: In real-life conditions and with the same antimicrobial stewardship programme (AMSP) led by a single team, the impact of PPRF was heterogeneous between ICUs. Factors driving the impact of AMSPs should be further assessed in comparable settings through real-life data, to target where they could prove cost-effective.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antimicrobial Stewardship/methods , Pseudomonas Infections/drug therapy , Carbapenems/therapeutic use , Drug Resistance, Multiple, Bacterial , Drug Utilization/statistics & numerical data , Humans , Intensive Care Units , Interrupted Time Series Analysis , Pseudomonas aeruginosa/drug effects , Retrospective Studies
2.
J Hosp Infect ; 84(1): 38-43, 2013 May.
Article in English | MEDLINE | ID: mdl-23433868

ABSTRACT

BACKGROUND: In Europe, including France, a measles outbreak has been ongoing since 2008. Unprotected healthcare workers (HCWs) may contract and spread the infection to patients. AIM: The objective of this study was to evaluate HCWs' measles immunity and vaccine acceptance in our setting. METHODS: In a survey-based study conducted in three university hospitals in Paris, 351 HCWs were included between April and June 2011. The following data were collected at enrolment: age, hospital unit, occupation, history of measles infection and vaccination, previous measles serology and acceptance of a measles vaccination in case of seronegativity. Sera were tested for the presence of specific anti-measles IgG antibodies using the CAPTIA(®) measles enzyme-linked immunosorbent assay. FINDINGS: The mean age of the participating HCWs was 36 years (range: 18-67) and 278 (79.2%) were female. In all, 104 four persons (29.6%) declared a history of measles, and 90 (25.6%) declared never having received a measles vaccination. Among the 351 HCWs included in the study, 322 (91.7%) were immunized against measles (IgG >90 mIU/mL). The risk factors for not being protected were age [18-29 years, adjusted odds ratio: 2.7 (95% confidence interval: 1.1-6.9) compared with ≥30 years], no history of measles infection or vaccination. The global acceptance rate for a measles vaccination, before knowing their results, was 78.6%. CONCLUSION: In this cohort of HCWs, 8.3% were susceptible to measles; the group most represented were aged <30 years. Acceptance of the measles vaccine was high. A vaccination campaign in healthcare settings should target specifically healthcare students and junior HCWs.


Subject(s)
Disease Outbreaks/prevention & control , Health Personnel/statistics & numerical data , Measles Vaccine/administration & dosage , Measles/prevention & control , Patient Acceptance of Health Care/statistics & numerical data , Vaccination/statistics & numerical data , Adolescent , Adult , Antibodies, Viral/blood , Enzyme-Linked Immunosorbent Assay , Female , Hospitals/standards , Humans , Immunity , Immunoglobulin G/blood , Logistic Models , Male , Measles/epidemiology , Paris/epidemiology , Surveys and Questionnaires , Young Adult
3.
Ann Ig ; 23(4): 329-36, 2011.
Article in Italian | MEDLINE | ID: mdl-22026236

ABSTRACT

Exposure to dioxin has been associated with the development of various kind of cancer. In the town of Trieste there is a contaminated site of national interest (according to law) and the incidence rate of cancer is the highest in Friuli Venezia Giulia. Using "main residence" it was possible to map soft tissues sarcomas (ICD-IX-171), in order to detect possible clusters or incidence gradients. Available data do not point out any statistically significant difference between observed and expected cases, applying pooled means from North Italy Cancer Registers. This work did not highlighted a correlation between residence in supposed polluted areas and rates of incidence of Soft tissue sarcomas.


Subject(s)
Sarcoma/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Environmental Pollution/adverse effects , Female , Humans , Italy/epidemiology , Male , Middle Aged , Time Factors , Young Adult
4.
J Hosp Infect ; 54(2): 158-60, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12818591

ABSTRACT

The epidemiology, risk factors, maternal and neonatal outcomes of nosocomial Pseudomonas aeruginosa acquisition in preterm premature rupture of membranes were analysed. Of 63 women receiving antibiotic prophylaxis with co-amoxiclav, 11 acquired P. aeruginosa vaginal carriage with a median delay of 15 days (6-42) i.e. an incidence of 8.94 per 1000 days of expectant management. Five neonates born to 11 positive mothers were colonized or infected, three of whom died of fulminant sepsis. The duration of antibiotic treatment and multiple pregnancy were identified as independent risk factors. The epidemiological investigation revealed a vertical transmission between mothers and neonates, and suggested selective pressure of antibiotic treatment.


Subject(s)
Carrier State , Communicable Diseases, Emerging/etiology , Cross Infection/etiology , Fetal Membranes, Premature Rupture/complications , Infant, Newborn, Diseases/etiology , Infectious Disease Transmission, Vertical/statistics & numerical data , Pregnancy Complications, Infectious , Pregnancy Complications, Infectious/etiology , Pseudomonas Infections/etiology , Pseudomonas aeruginosa , Adult , Antibiotic Prophylaxis , Carrier State/epidemiology , Carrier State/prevention & control , Carrier State/transmission , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/prevention & control , Communicable Diseases, Emerging/transmission , Cross Infection/epidemiology , Cross Infection/prevention & control , Cross Infection/transmission , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Incidence , Infant, Newborn , Infant, Newborn, Diseases/epidemiology , Infant, Newborn, Diseases/prevention & control , Infection Control , Infectious Disease Transmission, Vertical/prevention & control , Parity , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/prevention & control , Pregnancy Outcome , Prospective Studies , Pseudomonas Infections/epidemiology , Pseudomonas Infections/prevention & control , Pseudomonas Infections/transmission , Pseudomonas aeruginosa/genetics , Risk Factors , Time Factors , Vagina/microbiology
5.
Scand J Infect Dis ; 32(3): 322-3, 2000.
Article in English | MEDLINE | ID: mdl-10879608

ABSTRACT

A 48-y-old woman, with a previous history of neurosurgical intervention for a trigeminal neurinoma, presented with acute meningitis due to Streptococcus salivarius. There were significant changes in the petrous region, as revealed by MRI, leading to the diagnosis of associated latent subacute mastoiditis.


Subject(s)
Mastoiditis/microbiology , Meningitis, Bacterial/complications , Streptococcal Infections/complications , Acute Disease , Female , Humans , Magnetic Resonance Imaging , Mastoiditis/diagnosis , Mastoiditis/etiology , Meningitis, Bacterial/diagnosis , Middle Aged , Streptococcal Infections/diagnosis , Streptococcus/isolation & purification
6.
Antimicrob Agents Chemother ; 44(8): 2201-4, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10898703

ABSTRACT

From genomic DNA of Ralstonia pickettii isolate PIC-1, a beta-lactamase gene was cloned that encodes the oxacillinase OXA-22. It differs from known oxacillinases, being most closely related to OXA-9 (38% amino acid identity). The hydrolytic spectrum of OXA-22 is limited mostly to benzylpenicillin, cloxacillin, and restricted-spectrum cephalosporins. OXA-22-like genes were identified as single chromosomal copies in five other R. pickettii clinical isolates. The expression of OXA-22-like beta-lactamases was inducible in R. pickettii.


Subject(s)
Pseudomonas/genetics , beta-Lactamases/genetics , Amino Acid Sequence , Anti-Bacterial Agents/pharmacology , Chromosomes, Bacterial , Cloning, Molecular , Enzyme Induction , Humans , Microbial Sensitivity Tests , Molecular Sequence Data , Pseudomonas/drug effects , Pseudomonas/enzymology , Pseudomonas/metabolism , Sequence Homology, Amino Acid , beta-Lactam Resistance/genetics , beta-Lactamases/biosynthesis , beta-Lactams
7.
Antimicrob Agents Chemother ; 42(11): 2889-92, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9797221

ABSTRACT

Of 24 high-level gentamicin-resistant clinical isolates of Enterococcus faecalis, 20 carried gentamicin resistance (Gmr) plasmids. The plasmids ranged from 65.0 to 80.0 kb in size. Three of these plasmids were nonconjugative, and 17 transferred by conjugation to an E. faecalis recipient at low frequency (10(-5) to 10(-6) transconjugants per donor). The remaining four strains had a nonconjugative chromosomal Gmr determinant. On the basis of restriction enzyme and DNA-DNA hybridization profiles, Tn4001-like alpha elements were located on the chromosome and three types of Tn4001-truncated structures, I, II, and III, were found to be carried by the Gmr plasmids. Structure I lacked IS256 in the right-hand flanking extremity of Tn4001. Structure II was the same as structure I except that it also had a partial deletion of IS256 in the left-hand flanking extremity of Tn4001. Structure III lacked both the right- and left-hand flanking extremities of Tn4001. One of the wild-type strains carried the Gmr determinant both on the chromosome, as a Tn4001-like alpha element, and on a conjugative plasmid, as a Tn4001-truncated type I structure.


Subject(s)
Enterococcus faecalis/drug effects , Genes, Bacterial , Gentamicins/pharmacology , Chromosome Mapping , Conjugation, Genetic , DNA/analysis , DNA Transposable Elements , Drug Resistance, Microbial/genetics , Enterococcus faecalis/genetics , Humans , Plasmids
8.
Antimicrob Agents Chemother ; 42(8): 2074-83, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9687410

ABSTRACT

The Pseudomonas aeruginosa Mus clinical isolate produces OXA-18, a pI 5.5 class D extended-spectrum beta-lactamase totally inhibited by clavulanic acid (L. N. Philippon, T. Naas, A.-T. Bouthors, V. Barakett, and P. Nordmann, Antimicrob. Agents Chemother. 41:2188-2195, 1997). A second beta-lactamase was cloned, and the recombinant Escherichia coli clone pPL10 expressed a pI 7.4 beta-lactamase which conferred high levels of amoxicillin and ticarcillin resistance and which was partially inhibited by clavulanic acid. The 2.5-kb insert from pPL10 was sequenced, and a 266-amino-acid protein (OXA-20) was deduced; this protein has low amino acid identity with most of the class D beta-lactamases except OXA-2, OXA-15, and OXA-3 (75% amino acid identity with each). OXA-20 is a restricted-spectrum oxacillinase and is unusually inhibited by clavulanic acid. OXA-20 is a peculiar beta-lactamase because its translation initiates with a TTG (leucine) codon, which is rarely used as a translational origin in bacteria. Exploration of the genetic environment of oxa20 revealed the presence of the following integron features: (i) a second antibiotic resistance gene, aacA4; (ii) an intI1 gene; and (iii) two 59-base elements, each associated with either oxa20 or aacA4. This integron is peculiar because it lacks the 3' conserved region, and therefore is not a sul1-associated integron like most of them, and because its 3' end is located within tnpR, a gene involved in the transposition of Tn5393, a gram-negative transposon. P. aeruginosa Mus produces two novel and unrelated oxacillinases, OXA-18 and OXA-20, both of which are inhibited by clavulanic acid.


Subject(s)
DNA Transposable Elements , Pseudomonas aeruginosa/enzymology , beta-Lactamases/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Microbial Sensitivity Tests , Molecular Sequence Data , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/genetics , Sequence Homology, Amino Acid
9.
Rev Med Interne ; 18(12): 972-4, 1997.
Article in French | MEDLINE | ID: mdl-9500001

ABSTRACT

Leuconeutropenia is a common manifestation of acute brucellosis, whereas other hematological abnormalities and pancytopenia are uncommon. We report a patient presenting with acute brucellosis and pancytopenia.


Subject(s)
Brucellosis/complications , Pancytopenia/etiology , Acute Disease , Adult , Female , Humans
11.
Antimicrob Agents Chemother ; 37(10): 2159-65, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8257139

ABSTRACT

In 1990, over a 6-month period, an increase from 1 to 10% in the incidence of pristinamycin resistance among coagulase-negative staphylococci was observed in four intensive care units of a Parisian hospital. Twenty-three such isolates, as well as 25 pristinamycin-susceptible Staphylococcus epidermidis isolates, were collected and typed by analyzing various bacterial constituents. Two structurally related plasmids of 7.3 and 14.3 kb, carrying the gene vga encoding resistance to pristinamycin, were detected in the 23 pristinamycin-resistant coagulase-negative staphylococci which were identified as S. epidermidis. Although related by numerous common characteristics, 20 of these 23 isolates could be divided into two types, A (17 isolates) and B (three isolates). These types were characterized on the basis of their plasmid contents and hybridization patterns obtained when the EcoRI-digested DNA was probed with plasmid pIP1551 containing an internal fragment of the insertion sequence IS256. These findings suggest that the dissemination of type A epidemic strains was, in large part, responsible for the outbreak.


Subject(s)
Cross Infection/microbiology , Staphylococcal Infections/microbiology , Staphylococcus epidermidis/classification , Virginiamycin/pharmacology , Base Sequence , Cross Infection/drug therapy , DNA Probes , Drug Resistance, Microbial , Humans , Immunoblotting , Molecular Sequence Data , Nucleic Acid Hybridization , Paris , Phenotype , Plasmids/genetics , Staphylococcal Infections/drug therapy , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/genetics
12.
Pathol Biol (Paris) ; 39(7): 700-8, 1991 Sep.
Article in French | MEDLINE | ID: mdl-1758723

ABSTRACT

Vancomycin is a narrow-spectrum glycopeptide antibiotic which is primarily active against Gram-positive organisms. Bacterial resistance develops rarely due to its numerous modes of action. The mode of action of vancomycin involves the inhibition of peptidoglycan synthesis. Vancomycin forms a stoichiometric complex with the peptidoglycan precursor UDP-N-acetylmuramyl pentapeptide by forming hydrogen bonds. In patients with renal insufficiency vancomycin clearance is reduced and elimination half-life prolonged. Vancomycin is the drug of choice in the treatment of methicillin-resistant staphylococcal infections and in the treatment of Gram-positive endocarditis and has been used as alternative therapy in the treatment or prophylaxis of Gram-positive infections in penicillin-allergic patients.


Subject(s)
Vancomycin , Cell Division/drug effects , Drug Resistance, Microbial , Enterococcus/drug effects , Gram-Positive Bacteria/cytology , Gram-Positive Bacteria/metabolism , Peptidoglycan/biosynthesis , Peptidoglycan/drug effects , Vancomycin/administration & dosage , Vancomycin/pharmacokinetics , Vancomycin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...